Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA
Eisai Co Ltd (AMEX: ESALF) Delayed: 30.61 --0 (-0%)
Previous Close $30.61    52 Week High $66.25 
Open $30.61    52 Week Low $53.50 
Day High $30.61    P/E N/A 
Day Low $30.61    EPS $0.00 
Volume 1       

Eisai Co Ltd American Depositary Shares (AMEX: ESALY) Delayed: 61.51 --0 (-0%)
Previous Close $61.51    52 Week High $67.60 
Open $49.73    52 Week Low $53.55 
Day High $61.51    P/E N/A 
Day Low $61.51    EPS $0.00 
Volume 1,907,007       

Merck & Co. (NYSE: MRK) Delayed: 147.15 --0 (-0%)
Previous Close $147.15    52 Week High $65.46 
Open $147.15    52 Week Low $47.97 
Day High $147.15    P/E 100.10 
Day Low $147.15    EPS $1.47 
Volume 6,225